Related Experiment Video
Updated: Aug 4, 2026

05:12
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
4.1K
Endoscopic Thyroidectomy With Level Vb Dissection Via a Chest-breast Approach: Technical Updates for Selective
Jinlong Huo1, Youming Guo2, Xiaochi Hu2
1First People's Hospital of Zunyi/Third Affiliated Hospital of Zunyi Medical University.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
|April 26, 2021
Summary
Endoscopic thyroidectomy with chest-breast approach allows for level Vb dissection, proving feasible for selected papillary thyroid carcinoma patients with lymph node metastasis. This minimally invasive technique offers a viable alternative to open surgery.
Area of Science:
- Surgical Oncology
- Endocrine Surgery
- Minimally Invasive Surgery
Background:
- Traditional open thyroidectomy can result in visible neck scarring.
- Endoscopic approaches offer potential cosmetic benefits and reduced invasiveness.
- Level Vb lymph node dissection is crucial for certain thyroid cancer staging.
Purpose of the Study:
- To assess the feasibility of endoscopic thyroidectomy incorporating level Vb lymph node dissection via a chest-breast approach.
- To evaluate the safety and efficacy of this novel surgical technique.
Main Methods:
- A retrospective analysis of 12 patients undergoing endoscopic thyroidectomy with chest-breast approach and level Vb dissection.
- Data collected included demographic information, surgical outcomes, and adverse events.
- Comparison with previously reported endoscopic lateral neck dissections.
Main Results:
- Successful completion in all 12 cases without conversion to open surgery.
- Average dissection times: 154.6 minutes (total), 276.3 minutes (lateral neck).
- Low complication rate: 1 lymphatic leakage, 2 transient hypocalcemia; no major adverse events or recurrence observed.
Conclusions:
- Endoscopic thyroidectomy with level Vb dissection using a chest-breast approach is feasible.
- This technique provides an alternative surgical option for papillary thyroid carcinoma patients with metastasis in levels II, III, IV, and Vb.

